undamentalytics Newsletter
Sign in

Clene Inc. balance sheet

At the end of fiscal 2025, Clene Inc. had total assets of $18.1m, total liabilities of $35.7m and shareholders' equity of −$17.6m. It held $5.2m in cash against $17.8m of debt.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents5950182912510
Receivables0000000
Inventory0000000
Total current assets6355293916915
Total assets68634452271823
Accounts payable1232111
Deferred revenue (current)00—————
Total current liabilities126142510115
Short-term debt6——————
Long-term debt2149251818
Total debt8141625111819
Total liabilities68504139363648
Shareholders' equity013313−9−18−25
Shares outstanding———6m8m11m13m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: CLDX vs CLNNCLNN vs CRVOCLNN vs IBIO

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Clene Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Clene Inc.